Cullin 4B/CUL-4B Antibody (Rabbit mAb) [J23G17]

Catalog No.: F7048

    Application: Reactivity:
    • Lane 1: Hela, Lane 2: 293T, Lane 3: 3T3, Lane 4: PC-12
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:1000
    1:30
    1:500
    1:50
    1:500
    Application
    WB, IP, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    104 kDa 104 kDa,36 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Mouse testis tissue; Human breast carcinoma tissue; Rat testis tissue; Human testis tissue; Mouse breast cancer tissue; Mouse liver tissue; HeLa cells; 293T cells; NIH/3T3 cells; PC-12 cells; A375 cells; HEK-293 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Cullin 4B/CUL-4B Antibody (Rabbit mAb) [J23G17] detects endogenous levels of total Cullin 4B/CUL-4B protein.
    タンパク質の局在
    細胞質、細胞核
    Uniprot ID
    Q13620
    Clone
    J23G17
    Synonym(s)
    KIAA0695, Cullin-4B, CUL-4B
    Background
    CUL4B is a cullin family scaffold protein that forms the core of CUL4B‑RING E3 ubiquitin ligase complexes and organizes modular CRL4B assemblies that catalyze polyubiquitination and proteasomal degradation of defined sets of cell‑cycle, chromatin, and signaling regulators. The protein shares high sequence similarity with CUL4A but contains an extended N‑terminal region that includes a nuclear localization signal and supports predominant nuclear localization, and its C‑terminal cullin domain binds the RING finger protein RBX1, while the adaptor DDB1 bridges CUL4B to a variable set of DCAF substrate receptors that confer target specificity. CRL4B complexes use DCAF adaptors such as Cdt2, AMBRA1, DDB2, TRPC4AP, and DCAF12 to recognize substrates including CDT1, cyclin E, cyclin D isoforms, p21, histones H2A, H3, and H4, and specific mitochondrial or signaling proteins, and CUL4B acts as a rigid scaffold that positions bound substrates and the E2–ubiquitin conjugate to promote Lys48‑linked polyubiquitination and subsequent proteasomal degradation. Nuclear CRL4B–DDB1–DDB2 complexes are targeted to UV‑damaged chromatin and monoubiquitinate histone H2A and other chromatin components at sites of DNA damage, functions that contribute to nucleotide excision repair, replication licensing control through CDT1 turnover, and maintenance of genome stability. CUL4B also regulates the mammalian target of rapamycin complex 1 (mTORC1) pathway through interaction with the mTOR component MLST8 and proteasome‑dependent ubiquitination events, linking CRL4B activity to control of cell growth, size, and metabolism. In G1–S progression, the DCX(AMBRA1) CRL4B complex ubiquitinates phosphorylated cyclin‑D family proteins and Elongin C from CRL5 complexes, and CUL4B participates with CUL4A in ubiquitination of cyclin E, thereby shaping cyclin–CDK activity profiles and enforcing proper G1 duration and S‑phase entry. CRL4B complexes that incorporate TRPC4AP or DCAF12 act in the DesCEND pathway and recognize C‑terminal degrons in substrates to trigger their degradation, extending CUL4B function into C‑end quality control and turnover of specific regulatory proteins. In immune cells, CUL4B‑RING E3 ligases regulate differentiation and effector functions of CD4⁺ T cells and other subsets by controlling the stability of transcription factors and signaling intermediates, and CRL4B activity aligns with regulation of cytokine production, Toll‑like receptor signaling, and maintenance of immune homeostasis. Oncogenic roles of CUL4B include overexpression and amplification in colorectal, bladder, breast, and other cancers, where CRL4B complexes promote cell proliferation, invasion, and epithelial–mesenchymal transition through multiple mechanisms that involve inactivation of p53 signaling, activation of Wnt/β‑catenin pathways, and cooperation with histone deacetylase‑containing corepressor complexes. In colorectal cancer, CUL4B acts as a negative regulator of p53 by interacting with MDM2, decreasing p53 half‑life, and reducing levels of p53 downstream targets such as p21 and PUMA, which supports tumor cell proliferation, invasion, and progression. In breast cancer, CRL4B binds MTA1/NuRD, SIN3A, CoREST, and NCoR/SMRT complexes, co‑occupies E‑cadherin and AXIN2 promoters, and coordinates with transcription factors such as Snail and ZEB2 to repress epithelial genes, enhance EMT signaling under hypoxia, and promote cancer stem‑cell–like properties; HIF‑1α directly activates, and ERα–GATA3 represses, CUL4B transcription, placing CUL4B under control of hypoxia and hormone pathways during tumor progression. Across developmental, immune, and oncogenic contexts, CUL4B functions as a nuclear cullin scaffold that assembles DDB1‑ and DCAF‑based CRL4B E3 ligases to couple substrate‑specific ubiquitination of DNA replication factors, cyclins, histones, signaling proteins, and transcriptional repressors with cell‑cycle control, chromatin remodeling, DNA repair, mTOR signaling, immune differentiation, and tumorigenesis.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください